期刊文献+

CTX对2型糖尿病肾病的治疗作用 被引量:5

Therapeutic effect of cyclophosphamide on type 2 diabetic nephropathy in rats
下载PDF
导出
摘要 目的探讨环磷酰胺(CTX)对2型糖尿病肾病大鼠蛋白尿的治疗作用。方法 80只SD雄性大鼠随机分为对照组(N组,n=14)、高脂饮食组(HF组,n=66)。HF组给予高脂饲料8周,产生胰岛素抵抗后,一次性腹腔注射STZ(35 mg/kg),对照组给予常规饲料,腹腔注射等量的柠檬酸-柠檬酸钠缓冲液。2型糖尿病肾病造模成功后,又将成模大鼠随机分为2型糖尿病肾病模型组(DN组,n=18)及治疗组(CTX组,n=36)。CTX组腹腔注射给予环磷酰胺(CTX)30 mg/kg,N组及DN组给予等量的生理盐水腹腔注射。两组均为每周一次,连续4周。测三组大鼠24 h尿蛋白定量,心脏取血测尿素氮(BUN)、肌酐(Scr),计算肾脏肥大指数(KHI),光镜下观察肾脏病理改变。结果①腹腔注射STZ后14 d,HF组与N组血糖、尿蛋白定量比较,差异有统计学意义(P<0.01);②环磷酰胺治疗4周后疗效比较,尿蛋白定量在N组、DN组、CTX组的中位数分别是13.08 mg/24 h、54.19 mg/24 h、43.30 mg/24 h,三组差异有统计学意义(P<0.01);③DN组尿素氮及肌酐较其他两组高,CTX组的尿素氮高于N组,差异有统计学意义(P<0.05),肌酐在CTX组与N组间差异无统计学意义(P>0.05);④DN组表现有肾小球系膜细胞增生,基底膜增厚,间质有炎性细胞浸润,间质纤维化,CTX组上述病理改变较DN组明显减轻,但较N组明显。结论环磷酰胺能够减少2型糖尿病肾病大鼠的蛋白尿、能减轻肾功能损害并能使病理改变减轻。 Objective To explore the therapeutic action of eyclophosphamide (CTX) on proteinufia in rats with type 2 diabetic ne- phropathy. Methods Eighty male SD rats were randomly divided into normal group (n = 14) and high-fat group (n = 66 ). Rats in high-fat group were given high-fat diet for 8 weeks ,and they were intraperitoneally injected with low-dose of STZ (35 mg/kg) after in- sulin resistance ; while the rats in normal group were given the routine diet and injected with the same volume of citric acid-citrate sodi- um buffer. After type 2 diabetic nephropathy model was established successfully, DN rats were divided into two groups:DN group( n = 18) and medication group (CTX group,n =36). The rats were given CTX 30 mg/kg in CTX group and the same amount of physiologi- eal saline in the other two groups once a week for 4 weeks. Then 24 h urine protein, BUN and Scr in three groups were detected, kidney hypertrophy index was calculated, and renal pathology was observed under light mieroseope. Results (1)At 14 d after injected with STZ, the levels of blood sugar and urinary albumen were different between high-fat group and normal group ( P 〈 0.01 ). (2)After admin- istrating CTX for 4 weeks ,median of urinary albumen was 13.08 mg/24 h ,54.19 mg/24 h,43.30 mg/24 h in normal group, DN group and CTX group, respectively, and there was significant difference among three groups. (3)The levels of BUN and Ser were significantly higher in DN group than those in the other two groups (P 〈 0. 05 ). The level of BUN in CTX group was signifieantly higher than in nor- real group(P 〈0.05 ) ,but there was no difference in Scr between CTX group and normal group(P 〉 0.05 ). (4)Renal pathology showed glomerular mesangial eell proliferation,basement-membrane thiekening, inflammatory cell invasion and renal interstitial fibrosis in DN group. The pathological changes were signifieanfly alleviated in CTX group, but were severer than in normal group. Conclusion CTX can decrease the proteinuria and lighten the injury of renal function in rats with type 2 diabetic nephropathy.
出处 《山西医科大学学报》 CAS 2012年第8期571-575,636,637,共7页 Journal of Shanxi Medical University
基金 陕西省科技攻关项目(No.2009K01-83)
关键词 环磷酰胺 糖尿病肾病 动物模型 蛋白尿 肾脏病理 eyclophosphamide diabetic nephropathy animal model proteinuria renal pathology
  • 相关文献

参考文献11

二级参考文献90

  • 1隋蕾,李素梅,叶山东,翟志敏,陈若平,陈超,荆春艳,何媛媛,林杨,孙致连.糖尿病肾病患者外周血单核细胞NF-κB和单核细胞趋化蛋白-1蛋白表达的变化及意义[J].中国现代医学杂志,2008,18(21):3210-3213. 被引量:1
  • 2吴松华,项坤三,郑泰山,孙多奇,翁青,赵红华,李杰.Relationship between the renin angiotensin system genes and diabetic nephropathy in the Chinese[J].Chinese Medical Journal,2000(5):53-57. 被引量:6
  • 3叶迎春,李竞,甘佩珍,包艳,李芳林.缬沙坦对糖尿病大鼠肾脏MCP-1表达的影响[J].实用医学杂志,2004,20(8):866-868. 被引量:2
  • 4Danda RS, Habiba NM, Rincon-Choles H, et al. Kidney involvement in a nongenetic rat model of type 2 diabetes[ J]. Kidney International, 2005,68 (6) :2562.
  • 5Hafner SM, Gonzalez C, Miettinen H, et al. A prospective analysis of the Homa model J.The Mexico city diabetes study[J]. Diabetes Care, 1996, 19(10) : 1138.
  • 6Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome M[ J]. Nature, 2006,444( 7121 ) :881.
  • 7Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes[J]. Nature,2006,444(7121 ) :840.
  • 8Chen S, Evans T, Deng D, et al. Hyperhexosemia induced functional and st ructural changes in the kidneys: role of endothelins[ J]. Nephron, 2002,90 (1):86.
  • 9Abboud H. Growth factors and diabetic nephrology: an overview[ J ]. Kidney Int, 1997,60:S3.
  • 10Guo M, Ricardo SD, Dearie JA, et al. A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy [J] .J Anat,2005,207(6):813.

共引文献277

同被引文献66

  • 1崔瑾,张鹏,邱明才,李德强,张鑫,张金石.环孢素A对链脲菌素诱导的糖尿病大鼠心脏免疫球蛋白异常沉积的影响[J].中华糖尿病杂志,2010,2(2). 被引量:4
  • 2李才锐,孙曙光,姜德咏,洪卫.银杏叶提取物治疗早期糖尿病视网膜病变观察[J].国际眼科杂志,2006,6(1):78-81. 被引量:36
  • 3鲍荣辉,刘先哲.单核细胞趋化蛋白研究进展[J].医学研究杂志,2006,35(4):58-60. 被引量:5
  • 4TESCH GH,ALLEN TJ.Rodent models of streptozotocin-in-duced diabetic nephropathy[J].Nephrology,2007,12:261-266.
  • 5MORA C,NAVARRO JF.The role of inflammation as patho-genic factor in the development of renal disease in diabetes[J].Curr Diab Rep,2005,5(6):399-400.
  • 6ELMMARAKBY AA,SULLIVAN JC.Relationship betweenoxidative stress and inflammatory cytokines in diabetic nephrop-athy[J].Cardiovasc Therapeut,2012,30:49-59.
  • 7XU Y,YANG S,HUANG J,et al.TGF-β1induces autophagyand promotes apoptosis in renal tubular epithelial cells[J].IntMo1 Med,2012,29(5):781-790.
  • 8QI MY,CHEN K,LIU HR,et al.Protective effect of Icariinon the early stage of experimental diabetic nephropathy inducedby streptozotocin via modulating transforming growth factorβ1and type IV collagen expression in rats[J].J Ethnopharmacol,2011,138(3):731-736.
  • 9EL MESALLAMY HO,AHMED HH,BASSYOUNI AA,etal.Clinical significance of inflammatory and fibrogenic cyto-kines in diabetic nephropathy[J].Clin Biochem,2012,45(9):646-650.
  • 10罗志峰,牟娇,齐伟,等.4一苯基丁酸对糖尿病肾病大鼠的作用[J].中华肾脏病杂志,2012,26(5):358-362.

引证文献5

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部